The story of Sildenafil presents a challenging picture for those considering investment. While the initial release generated substantial gains, the expiration of its patent opened the door to off-brand alternatives, dramatically eroding market share. This presents a unique challenge for drug manufacturers depending on comparable blockbuster offerin

The legacy of Viagra, and its creator copyright, presents a complex case study for investors. At first a blockbuster drug, producing billions in income, its intellectual property lapse created a wave of generic competition , significantly impacting its dominance. While some businesses may try to capitalize on similar conditions , the current landsc